Pogosov
Market closed · Pre-market opens in
EN|RU
--:--:--NY

← ANALYST RATINGS · TIPRANKS

Veeva Systems (VEEV): analyst forecast and price target

$310 −0.85% close 16.10.26 · market cap $50.7B · Healthcare · Software - Application SPY 0.07%
Price targets and ratings of
All analysts Top analysts

Analyst consensus

Moderate Buy

17 Buy6 Hold1 Sell

Ratings of 24 analysts in the last 3 months

12-month forecast

$294−5.4% downside

Based on 24 price targets given in the last 3 months, the average target is $294, the highest $340, the lowest $180. The average is −5.4% from the last price of $310.

$200$300Jan 26AprJulOctJan 27AprJulOctHigh$340Average$294Low$180
Highest target $340 Average target $294 Lowest target $180

Analyst ratings 29

Analysts TipRanks AI models 18 All
Any rating BuyHoldSell
All actions Only changes
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Joseph Vruwink★★★★★★★★★★#1159 · hits 59% · avg +7.8% Robert W. Baird $300 Buy −3.3% Reiterated 09.10.26on TipRanks 08:50 +3.4%next day 0.0% · 5 days +6.8% ↗
Stan Berenshteyn★★★★★★★★★★#11485 · hits 50% · avg −5.0% Wells Fargo $330 Buy +6.3% Reiterated 30.09.26on TipRanks Oct 1 05:30 +2.7%next day −1.4% · 5 days −2.9% ↗
Stan Berenshteyn★★★★★★★★★★#11485 · hits 50% · avg −5.0% Wells Fargo $330 Buy +6.3% Reiterated 23.09.26on TipRanks Sep 24 05:30 +4.5%next day +1.6% · 5 days +6.1% ↗
Craig Hettenbach★★★★★★★★★★#1537 · hits 59% · avg +7.6% Morgan Stanley $275 Hold −11.4% Assigned 18.09.26on TipRanks 08:25 −1.5%next day −1.1% · 5 days +6.6% ↗
Unknown Analyst CFRA — Buy — Upgrade 16.09.26on TipRanks Sep 18 08:25 −0.2%next day −1.6% · 5 days +0.1% ↗
Charles Rhyee★★★★★★★★★★#1937 · hits 54% · avg +5.6% TD Cowen $283 Buy −8.8% Reiterated 15.09.26on TipRanks 14:50 +0.8%next day −0.2% · 5 days −4.5% ↗
Alexei Gogolev★★★★★★★★★★#2483 · hits 54% · avg +6.0% J.P. Morgan $299 Buy −3.7% Reiterated 01.09.26on TipRanks Sep 2 08:05 −1.6%next day +0.1% · 5 days −6.7% ↗
Tyler Radke★★★★★★★★★★#2747 · hits 50% · avg +4.2% Citi $190 → $273+43.7% Hold −12.0% Reiterated 28.08.26on TipRanks 06:30 −1.7%next day +3.6% · 5 days −0.7% ↗
Karl Keirstead★★★★★★★★★★#437 · hits 63% · avg +14.6% UBS $190 → $290+52.6% Hold −6.6% Assigned 28.08.26on TipRanks Aug 27 07:15 +14.5%next day −1.7% · 5 days +0.5% ↗
Brian Peterson★★★★★★★★★★#2160 · hits 49% · avg +5.3% Raymond James $225 → $330+46.7% Buy +6.3% Reiterated 27.08.26on TipRanks 08:31 +14.5%next day −1.7% · 5 days +0.5% ↗
Kenneth Wong★★★★★★★★★★#1613 · hits 52% · avg +7.5% Oppenheimer $300 → $325+8.3% Buy +4.7% Reiterated 27.08.26on TipRanks 08:30 +14.5%next day −1.7% · 5 days +0.5% ↗
Kirk Materne★★★★★★★★★★#1369 · hits 56% · avg +7.7% Evercore ISI $185 → $250+35.1% Hold −19.4% Reiterated 27.08.26on TipRanks 08:00 +14.5%next day −1.7% · 5 days +0.5% ↗
Sean Dodge★★★★★★★★★★#11980 · hits 43% · avg −4.3% BMO Capital $175 → $270+54.3% Hold −13.0% Assigned 27.08.26on TipRanks 07:25 +14.5%next day −1.7% · 5 days +0.5% ↗
Steven Valiquette★★★★★★★★★★#8240 · hits 53% · avg 0.0% Mizuho Securities $270 → $280+3.7% Buy −9.8% Reiterated 27.08.26on TipRanks 07:20 +14.5%next day −1.7% · 5 days +0.5% ↗
David Hynes★★★★★★★★★★#12301 · hits 38% · avg −10.3% Canaccord Genuity $220 → $260+18.2% Hold −16.2% Reiterated 27.08.26on TipRanks 07:05 +14.5%next day −1.7% · 5 days +0.5% ↗
Name not given — $276 → $310+12.3% Buy −0.1% Reiterated 27.08.26on TipRanks 07:05 +14.5%next day −1.7% · 5 days +0.5% ↗
Joseph Vruwink★★★★★★★★★★#1159 · hits 59% · avg +7.8% Robert W. Baird $260 → $300+15.4% Buy −3.3% Reiterated 27.08.26on TipRanks 07:00 +14.5%next day −1.7% · 5 days +0.5% ↗
David Grossman★★★★★★★★★★#4304 · hits 49% · avg +2.3% Stifel Nicolaus $275 → $300+9.1% Buy −3.3% Reiterated 27.08.26on TipRanks 06:50 +14.5%next day −1.7% · 5 days +0.5% ↗
Billy Fitzsimmons★★★★★★★★★★#3245 · hits 63% · avg +9.3% Piper Sandler $295 → $320+8.5% Buy +3.1% Reiterated 27.08.26on TipRanks 06:45 +14.5%next day −1.7% · 5 days +0.5% ↗
Ryan MacDonald★★★★★★★★★★#12366 · hits 37% · avg −11.1% Needham $310 Buy −0.1% Reiterated 27.08.26on TipRanks 06:45 +14.5%next day −1.7% · 5 days +0.5% ↗
Dylan Becker★★★★★★★★★★#3415 · hits 50% · avg +3.7% William Blair — Buy — Reiterated 27.08.26on TipRanks 06:25 +14.5%next day −1.7% · 5 days +0.5% ↗
Saket Kalia★★★★★★★★★★#966 · hits 56% · avg +9.0% Barclays $275 → $315+14.5% Buy +1.5% Reiterated 27.08.26on TipRanks Aug 26 04:15 −0.8%next day +14.5% · 5 days +14.7% ↗
Gabriela Borges★★★★★★★★★★#817 · hits 59% · avg +13.8% Goldman Sachs $165 → $180+9.1% Sell −42.0% Reiterated 26.08.26on TipRanks Aug 27 08:10 −0.8%next day +14.5% · 5 days +14.7% ↗
Rishi Jaluria★★★★★★★★★★#11899 · hits 52% · avg −4.1% RBC Capital $275 → $325+18.2% Buy +4.7% Reiterated 26.08.26on TipRanks Aug 27 07:25 −0.8%next day +14.5% · 5 days +14.7% ↗
David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% BTIG $340 Buy +9.6% Reiterated 26.08.26on TipRanks Aug 27 07:10 −0.8%next day +14.5% · 5 days +14.7% ↗
Jailendra Singh★★★★★★★★★★#12131 · hits 43% · avg −6.4% Truist Financial — Buy — Reiterated 26.08.26on TipRanks 08:07 −0.8%next day +14.5% · 5 days +14.7% ↗
Unknown Analyst Stephens $324 Buy +4.4% Reiterated 05.03.26on TipRanks 07:35 +4.6%next day +1.0% · 5 days −5.6% ↗
Bradley Sills★★★★★★★★★★#6686 · hits 44% · avg +0.6% Bank of America Securities $304 Hold −2.0% Reiterated 04.03.26on TipRanks Mar 5 06:11 +0.7%next day +4.6% · 5 days +0.5% ↗
Scott Schoenhaus★★★★★★★★★★#12104 · hits 35% · avg −9.7% KeyBanc — Hold — Downgrade 12.12.25on TipRanks 04:10 −1.6%next day −1.3% · 5 days −0.8% ↗

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Veeva Systems

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Stan Berenshteyn★★★★★★★★★★Wells Fargo · #11485
Hits 50%74 of 148 Average return −5.0%
1 year Saket Kalia★★★★★★★★★★Barclays · #966
Hits 56%270 of 481 Average return +9.0%
2 years Rishi Jaluria★★★★★★★★★★RBC Capital · #11899
Hits 52%259 of 500 Average return −4.1%

Most profitable

3 months Stan Berenshteyn★★★★★★★★★★Wells Fargo · #11485
Hits 50%74 of 148 Average return −5.0%
1 year Rishi Jaluria★★★★★★★★★★RBC Capital · #11899
Hits 52%259 of 500 Average return −4.1%
2 years Rishi Jaluria★★★★★★★★★★RBC Capital · #11899
Hits 52%259 of 500 Average return −4.1%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $294 at a price of $285 (+2.8%); now: $294 at $310 (−5.4%).

$260$280$300Sep 15Oct 1Oct 15Top analysts$289Average target$294Price$310

PriceAverage targetTop analysts’ target

Recommendation trend

020406034143Oct 2535132Nov30133Dec2394Jan 264933Feb121983Mar121591Apr111371May101381Jun111571Jul939132Aug23571Sep13371Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy111011921
Buy131315393533
Hold7871377
Sell111211

Earnings and sales forecast

Next report: 26.11.26 (Q3 2027, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $2.34 (from $2.32 to $2.40). Last quarter: $2.35.

Sales

Next quarter’s sales estimate — $935M (from $932M to $945M). Last quarter: $928M.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Veeva Systems
  • CEO: Peter Gassner
  • Employees: 7,928
  • 4280 Hacienda Drive, Pleasanton, CA, 94588, US
  • www.veeva.com

Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on da

Data from the stock’s TipRanks forecast page, read 26 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗